Picture of Titan Pharmaceuticals logo

TTNP — Titan Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Titan Pharmaceuticals Says On Aug 25 Entered Into Amendment,Extension Agreement With Respect To Certain Asset Purchase Agreement Dated July 26 With Fedson

Aug 30 (Reuters) - Titan Pharmaceuticals Inc  TTNP.O :
    * TITAN PHARMACEUTICALS-ON AUG 25 ENTERED INTO
AMENDMENT,EXTENSION
AGREEMENT WITH RESPECT TO CERTAIN ASSET PURCHASE AGREEMENT DATED
JULY 26 WITH FEDSON
    * TITAN PHARMACEUTICALS -  UNDER TERMS OF AMENDMENT FEDSON
WILL
PURCHASE PRONEURA ASSETS FROM COMPANY FOR A PURCHASE PRICE OF $2
MILLION
    * TITAN PHARMACEUTICALS INC - AMENDMENT EXTENDS CLOSING DATE
TO
SEPTEMBER 1, 2023
    * TITAN PHARMACEUTICALS INC - IN CONSIDERATION FOR SUCH
EXTENSION,
FEDSON PAID COMPANY AN ADVANCE OF $250,000 AGAINST CLOSING
CONSIDERATION

Source text for Eikon:  ID: 
Further company coverage:  TTNP.O 

 ((Reuters.Brief@thomsonreuters.com;))

Recent news on Titan Pharmaceuticals

See all news